CDC Commentary: Preventing Carbapenem-Resistant EnterobacteriaceaeRecent guidelines focus on limiting the emergence of carbapenemase-producing Enterobacteriaceae in acute care settings. Arjun Srinivasan, MD, provides guidance to clinicians in this video commentary.
February 2010
An Advance in Therapy for Patients With NSCLCDoes bevacizumab combined with pemetrexed and cisplatin provide improved efficacy in the treatment of non-small-cell lung cancer? Dr. Mark Kris examines the literature and answers this question.
Kris on Oncology, February 2010
Bevacizumab: When Is It Contraindicated in NSCLC Patients?Patient selection for bevacizumab therapy has changed since its FDA approval. In this video blog, Dr. Mark Kris addresses the absolute and relative contraindications to the use of this drug.
Kris on Oncology, February 2010
A Hospital Field Trip for the US CongressIn this video blog, Dr. John Marshall suggests that clinicians invite their senators and congressmen to their hospitals to get a first-hand view of what needs fixing in the US healthcare system.
Leading By Example to Fight H1N1 - Regina M. Benjamin, MD, MBAIn this video commentary, Dr. Regina M. Benjamin, Surgeon General, encourages health professionals to lead by example, getting H1N1 vaccinations themselves and recommending their patients do the same.
The Cuban Medical System -- More With LessIn this video blog, Robert Morrow, MD, reports on his trip to Cuba and tells us why observing its healthcare system "made him sad."
How confident are you in your ability to maximize outcomes (eg, improved quality of life, reduced respiratory infections) in treating patients with cystic fibrosis aged 40 years and older?